Evidence map›Paper›PMID 38383483›Full record

ArticleMicrobiome2024

Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging.

Shalini Singh, Leila B Giron, Maliha W Shaikh, Shivanjali Shankaran, Phillip A Engen, Zlata R Bogin, Simona A Bambi, Aaron R Goldman, Joao L L C Azevedo, Lorena Orgaz and 13 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Enrichment ofFrontiers in immunology · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Gut microbes · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

Shalini SinghVaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA.
Leila B GironVaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA.
Maliha W ShaikhRush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Shivanjali ShankaranRush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Phillip A EngenRush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Zlata R BoginRush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Simona A BambiRush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Aaron R GoldmanVaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA.
Joao L L C AzevedoVaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA.
Lorena OrgazLife Length, Madrid, Spain.
Nuria de PedroLife Length, Madrid, Spain.
Patricia GonzálezLife Length, Madrid, Spain.
Martin GieraCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Aswin VerhoevenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Elena Sánchez-LópezCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
Ivona PandreaUniversity of Pittsburgh, Pittsburgh, PA, USA.
Toshitha KannanVaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA.
Ceylan E TanesDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kyle BittingerDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Alan L LandayRush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Michael J CorleyWeill Cornell Medicine, New York, NY, USA.
Ali Keshavarzian *Rush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, USA.
Mohamed Abdel-Mohsen *Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA. mmohsen@Wistar.org.
Rush University · USThe Wistar Institute · USLife Length (Spain) · ESChildren's Hospital of Philadelphia · USLeiden University Medical Center · NLNetherlands Metabolomics Centre · NLUniversity of Pittsburgh · USWeill Cornell Medicine · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Aaron Robert Goldman · 1985 to 2026
$75.9M
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPsR01HL123096 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2015 to 2025
$6.8M
Role of Intestinal Barrier Integrity in Modulating the Host Glycome During COVID-19R01DK123733 · NIDDK · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, KESHAVARZIAN, ALI · 2020 to 2024
$4.5M
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIVR01MH134391 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley, Shelli Farhadian · 2023 to 2026
$3.8M
Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV InfectionR01AI165079 · NIAID · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, XIAO, HAN · 2021 to 2025
$3.1M
Sialic Acid Modulation of HIV-associated Chronic InflammagingR01AG062383 · NIA · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED · 2019 to 2023
$3.0M
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease RiskR01HL160392 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CORLEY, MICHAEL JAY · 2021 to 2024
$2.3M
Purchase of a Q Exactive HF mass spectrometer system for metabolomicsS10OD023586 · OD · WISTAR INSTITUTE · PI SPEICHER, DAVID W. · 2017 to 2017
$600k
NCI NIH HHS P30 CA010815NHLBI NIH HHS R01 HL123096NHLBI NIH HHS R01 HL160392NIAID NIH HHS R01 AI165079NIA NIH HHS R01 AG062383NIDDK NIH HHS R01 DK123733NIH HHS S10 OD023586NIMH NIH HHS R01 MH134391
6 · The paper itself

Abstract

backgroundPeople living with HIV (PLWH), even when viral replication is controlled through antiretroviral therapy (ART), experience persistent inflammation. This inflammation is partly attributed to intestinal microbial dysbiosis and translocation, which may lead to non-AIDS-related aging-associated comorbidities. The extent to which living with HIV - influenced by the infection itself, ART usage, sexual orientation, or other associated factors - affects the biological age of the intestines is unclear. Furthermore, the role of microbial dysbiosis and translocation in the biological aging of PLWH remains to be elucidated. To investigate these uncertainties, we used a systems biology approach, analyzing colon and ileal biopsies, blood samples, and stool specimens from PLWH on ART and people living without HIV (PLWoH) as controls.

resultsPLWH exhibit accelerated biological aging in the colon, ileum, and blood, as measured by various epigenetic aging clocks, compared to PLWoH. Investigating the relationship between microbial translocation and biological aging, PLWH had decreased levels of tight junction proteins in the intestines, along with increased microbial translocation. This intestinal permeability correlated with faster biological aging and increased inflammation. When investigating the relationship between microbial dysbiosis and biological aging, the intestines of PLWH had higher abundance of specific pro-inflammatory bacteria, such as Catenibacterium and Prevotella. These bacteria correlated with accelerated biological aging. Conversely, the intestines of PLWH had lower abundance of bacteria known for producing the anti-inflammatory short-chain fatty acids, such as Subdoligranulum and Erysipelotrichaceae, and these bacteria were associated with slower biological aging. Correlation networks revealed significant links between specific microbial genera in the colon and ileum (but not in feces), increased aging, a rise in pro-inflammatory microbe-related metabolites (e.g., those in the tryptophan metabolism pathway), and a decrease in anti-inflammatory metabolites like hippuric acid.

conclusionsWe identified specific microbial compositions and microbiota-related metabolic pathways that are intertwined with intestinal and systemic biological aging. This microbial signature of biological aging is likely reflecting various factors including the HIV infection itself, ART usage, sexual orientation, and other aspects associated with living with HIV. A deeper understanding of the mechanisms underlying these connections could offer potential strategies to mitigate accelerated aging and its associated health complications. Video Abstract.

Indexed as

Gastrointestinal MicrobiomeHIV InfectionsAgingAnti-Inflammatory AgentsBacteriaDysbiosisFemaleHumansInflammationIntestinesMaleAnti-Inflammatory AgentsAging clocksBiological agingGutHIVIntestinesMetabolomeMicrobiome

Identifiers

PMID38383483
PMCPMC10882811
OpenAlexW4392135492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.